AlphaGrep UK’s DexCom DXCM Stock Holding History

AlphaGrep UK’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,172	Closed	-$450K	–	791
2026 Q1	$450K	Sell	7,172 -1,157	-14%	-$80.6K	0.13%	302
2025 Q4	$553K	Buy	+8,329	New	+$538K	0.18%	177

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

AlphaGrep UK's DXCM Position: Q2 2026 in Review

AlphaGrep UK sold out of DexCom (DXCM) in Q2 2026, closing a stake of 7,172 shares — an estimated $450K sold.

AlphaGrep UK first reported a position in DXCM in Q4 2025 and held it in 2 quarters. The position peaked at $553K in Q4 2025. 919 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

AlphaGrep UK reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 7,172 DexCom shares in Q2 2026, an estimated $450K.
AlphaGrep UK first reported a position in DexCom in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's DexCom position peaked at $553K in Q4 2025.
919 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.